Lyssikatos Joseph P

EDGAR CIK 0001967150

Enliven Therapeutics, Inc. - ELVN

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Officer
CHIEF SCIENTIFIC OFFICER
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
12
($3.05) M
-119,347 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
04/21/2025
10b5-1
04/23/2025
Sell
-5,000 @ $16.07
 ($80,366) 997,688 (-0.50%) Indirect - See footnote
03/19/2025
10b5-1
03/21/2025
Sell
-12,500 @ $20.61
 ($257,575) 1,002,688 (-1.23%) Indirect - See footnote
10/18/2024
10b5-1
10/22/2024
Sell
-847 @ $30.00
 ($25,413) 1,015,188 (-0.08%) Indirect - See footnote
10/09/2024
10b5-1
10/10/2024
Sell
-37,878 @ $28.16
 ($1,066,561) 1,016,035 (-3.59%) Indirect - See footnote
10/08/2024
10b5-1
10/10/2024
Sell
-13,267 @ $27.97
 ($371,024) 1,053,913 (-1.24%) Indirect - See footnote
10/07/2024
10b5-1
10/08/2024
Sell
-2,707 @ $27.61
 ($74,727) 1,067,180 (-0.25%) Indirect - See footnote
10/04/2024
10b5-1
10/08/2024
Sell
-7,522 @ $27.51
 ($206,937) 1,069,887 (-0.70%) Indirect - See footnote
10/01/2024
10b5-1
10/03/2024
Sell
-527 @ $27.54
 ($14,512) 1,077,409 (-0.05%) Indirect - See footnote
08/29/2024
10b5-1
09/03/2024
Sell
-12,000 @ $22.49
 ($269,841) 1,077,936 (-1.10%) Indirect - See footnote
07/31/2024
10b5-1
08/02/2024
Sell
-3,099 @ $27.56
 ($85,399) 1,089,936 (-0.28%) Indirect - See footnote
07/29/2024
10b5-1
07/31/2024
Sell
-12,000 @ $26.70
 ($320,378) 1,093,035 (-1.09%) Indirect - See footnote
07/01/2024
10b5-1
07/03/2024
Sell
-12,000 @ $22.89
 ($274,736) 1,105,035 (-1.07%) Indirect - See footnote